DGE edges into the week on firmer ground, yet a yawning gap between where the stock trades and where analysts think it belongs frames the most interesting tension heading into October earnings.
The price recovery is real but modest. DGE closed at £16.39 on Tuesday, up 1.8% on the week and bouncing 1.5% on the day. That follows a bruising month — the stock is still down nearly 5% over 30 days. More striking is the distance to the analyst consensus target of £26.94, roughly 64% above the current price. That kind of implied return usually signals either a deeply undervalued recovery story or a Street that has been slow to reset its models. Given the persistent emerging-market headwinds that have dogged Diageo through 2026, the latter reading deserves at least equal weight. No recent analyst changes arrived to clarify direction, so the consensus number is best treated as a lagging anchor rather than an active buy signal.
The lending market tells a clean story: short sellers are not pressing hard here. Borrow availability is extremely loose, with over 1,380% of short interest still available to lend — well above the 52-week floor of 771% — meaning supply of shares to borrow vastly outstrips demand. Cost to borrow runs at just 0.59%, barely nudging 6% higher on the week from an already negligible base. The ORTEX short score has actually drifted lower over the past two weeks, from 52.4 on September 10 down to 50.8 now, suggesting mild but consistent short-side disengagement. The short score rank sits in the 21st percentile. This is not a stock where bears are stacking up.
The factor picture is more nuanced. EPS momentum is a genuine bright spot — both the 30-day and 90-day readings rank in the 81st percentile, and forward EPS growth ranks in the 79th. That tells you estimate revisions have been running upward, even as the stock has struggled. The fly in the ointment is EPS surprise, ranked at just the 11th percentile, meaning Diageo has historically tended to miss consensus on the actual print. The analyst recommendation differential scores only in the 5th percentile, an unusually poor reading that flags a broad analyst community not rushing to upgrade. Valuation multiples have contracted meaningfully over the past month — price/earnings has compressed by 1.2 turns to 12.5x and price/book has shed nearly 0.2 turns to 3.4x — which reflects the month's price weakness more than any fundamental re-rating.
The ownership register offers one thread worth watching. BlackRock holds 7.3% and added 5.2 million shares in the most recent reporting period. Artisan Partners, with a 5.3% stake, added 5.2 million as well. Causeway Capital built its position by nearly 7.9 million shares, and First Eagle added an unusually large 15.3 million. Invesco went further still, adding 18.7 million shares. That cluster of active managers buying into a falling stock suggests several institutional investors have decided the price dislocation is now large enough to act on — but none of these are recent enough to read as a fresh catalyst. The last-reported date for all of them is September 1. On the insider side, a batch of compensation grants hit the register on September 14 across senior executives including the CFO and CEO. All were unpriced grants rather than open-market purchases, so they carry little conviction signal.
The most concrete near-term anchor is the earnings event on October 29. Diageo's last result — the August 6 print — produced a 9.1% single-day gain and held 6.8% higher five days out. That was a sharp relief rally. Whether the setup into October 29 allows for a repeat depends on how much of the analyst optimism embedded in that £26.94 target filters through to guidance, and whether the China and Brazil demand story shows any early sign of floor.
See the live data behind this article on ORTEX.
Open DGE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
